Zymeworks Analyst Price Targets - Benzinga

Zymeworks Inc

ZYMENASDAQ

Trade with Public

Trade with Public

$24.92

-0.15-0.6%

Dern. MÀJ: Oct 14, 2:51 PM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

Zymeworks Analyst Price Targets

Wall Street analyst price targets and consensus rating for Zymeworks (ZYME).

Price Target Range — 11 Quarters

Analyst Consensus — 13 Analysts

1S.Buy

12Buy

Consensus RatingBuy# Analysts13Avg. Consensus PT$40Upside to Avg. PT+58.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	Truist Securities	Gregory Renza	PT Raise	Buy	$32→$34
Sep 29, 2026	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$38→$39
Sep 17, 2026	Wolfe Research	Kalpit Patel	Initiate	Outperform	—
Sep 3, 2026	JP Morgan	Brian Cheng	PT Raise	Overweight	$31→$33
Aug 26, 2026	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$37→$38
Aug 26, 2026	Citizens	Reni J. Benjamin	Maintained	Market Outperform	$32
Aug 26, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$51→$55
Aug 10, 2026	B. Riley Securities	Mayank Mamtani	PT Raise	Buy	$40→$44
Aug 7, 2026	Wells Fargo	Eva Fortea Verdejo	PT Raise	Overweight	$37→$40
Aug 7, 2026	Truist Securities	Gregory Renza	PT Raise	Buy	$31→$32
Aug 5, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$46→$51
Jul 7, 2026	Truist Securities	Gregory Renza	PT Raise	Buy	$28→$31
Jun 30, 2026	Wells Fargo	Eva Fortea Verdejo	PT Raise	Overweight	$34→$37
Jun 3, 2026	HC Wainwright & Co.	Robert Burns	Maintained	Buy	$46
May 8, 2026	Wells Fargo	Eva Fortea Verdejo	PT Raise	Overweight	$33→$34
Mar 9, 2026	Evercore ISI Group	Jonathan Miller	PT Raise	Outperform	$33→$48
Mar 6, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$32→$46
Mar 3, 2026	Stifel	Stephen Willey	PT Raise	Buy	$40→$47
Mar 3, 2026	Leerink Partners	Andrew Berens	PT Raise	Outperform	$52→$58
Dec 17, 2025	Truist Securities	Asthika Goonewardene	Initiate	Buy	$40

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Zymeworks, Raises Price Target to $34

Truist Securities analyst Gregory Renza maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $32 to $34.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Zymeworks, Raises Price Target to $39

Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $38 to $39.

Benzinga Newsdesk

PRO
Wolfe Research Initiates Coverage On Zymeworks with Outperform Rating

Wolfe Research analyst Kalpit Patel initiates coverage on Zymeworks (NASDAQ:ZYME) with a Outperform rating.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Zymeworks, Raises Price Target to $33

JP Morgan analyst Brian Cheng maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $31 to $33.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Zymeworks, Raises Price Target to $38

Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $37 to $38.

Benzinga Newsdesk

MongoDB To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday

Top analysts changed outlook on top names: Piper raised $INTU price target, Ascendiant raised $QUBT target, BTIG cut $DKS target, HC raised $ZYME target, Needham increased $JAZZ target, Bernstein cut $MSTR target, Barclays raised $MDB target, UBS raised $SMTC target.

Avi Kapoor